文献速递心外重症与机械循环支持

体外膜肺氧合作为桥接方法的评估

Evaluation of Extracorporeal Membrane Oxygenation Therapy as a Bridging Method.
PubMed 文献 · Ann Thorac Surg · 2020-10-22

基于联合国器官共享数据库2001至2018年成人心脏移植前需ECMO支持的患者,比较未用ECMO、撤除ECMO、直接ECMO桥接移植及ECMO桥接LVAD后移植四组结局。结果显示直接ECMO桥接移植者1年生存率显著低于先桥接LVAD再移植者(P < .001)。

要点

  • ECMO直接桥接心脏移植的1年生存率低于先桥接LVAD再移植。
  • 研究纳入未用ECMO、撤除ECMO、直接ECMO桥接及ECMO桥接LVAD四组患者。
  • 新心脏分配系统下需持续评估ECMO桥接策略的结局。

核心结论

  • ECMO桥接患者先过渡至LVAD再行移植,较直接ECMO桥接移植可改善1年生存率。

研究设计与样本

  • 回顾性队列研究,查询联合国器官共享数据库2001至2018年18岁及以上心脏移植前需ECMO支持的成人患者。
  • 按移植前ECMO使用情况分为未用ECMO组(29,370例)、撤除ECMO组(101例)、直接ECMO桥接移植组(118例)和ECMO桥接LVAD后移植组(55例)。

主要发现

  • Kaplan-Meier生存分析显示,直接ECMO桥接移植组1年生存率显著低于ECMO桥接LVAD后移植组(P < .001)。
  • 比较了 demographics 及结局包括1年生存、术后卒中、术后需透析的肾衰竭、排斥反应发作和移植物衰竭。

关键数值与推荐

  • 直接ECMO桥接移植组与ECMO桥接LVAD后移植组的1年生存率差异有统计学意义(P < .001)。

临床怎么用

  • 对于需要ECMO支持的心脏移植候选者,可考虑先桥接至LVAD再行移植以改善1年生存。
  • 在新心脏分配系统下,应持续评估ECMO桥接策略的结局以指导管理。

局限性

  • 原文未报告

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: With the implementation of the new heart allocation system, heart transplantation teams are prompted to reevaluate management of patients requiring mechanical circulatory support. The purpose of our study is to compare the outcomes of patients supported with extracorporeal membrane oxygenation (ECMO) before transplantation. METHODS: The United Network for Organ Sharing database was queried for all adult patients (aged 18 years or more) who required support with ECMO before heart transplantation from 2001 to 2018. Patients were stratified into patients who did not require ECMO before transplantation, who were weaned off ECMO before transplantation, who were bridged immediately to transplantation from ECMO, and who were bridged to a left ventricular assist device (LVAD) before transplantation. Demographics and outcomes including 1-year survival, postoperative stroke, postoperative renal failure requiring dialysis, episodes of rejection, and graft failure were compared. RESULTS: Overall, 29,370 patients did not require ECMO before transplantation, 101 patients were weaned off ECMO before transplantation, 118 were bridged from ECMO directly to transplantation, and 55 patients were successfully bridged from ECMO to LVAD before transplantation. Kaplan-Meier survival estimates found a statistically significant decrease in 1-year survival for patients who were bridged from ECMO to transplantation compared with patients who were bridged to LVAD before subsequent transplantation (P < .001). CONCLUSIONS: Our study suggests bridging ECMO patients to an LVAD before transplantation will result in improved 1-year survival compared with patients bridged to immediate transplantation. With the new heart allocation system, continued evaluation of outcomes is required to inform management strategies.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Lui C, Fraser CD, Suarez-Pierre A, et al. Evaluation of Extracorporeal Membrane Oxygenation Therapy as a Bridging Method. Ann Thorac Surg. 2020. PMID: 33098881. doi:10.1016/j.athoracsur.2020.08.041

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。